Skip to main content
Celularity Inc. (CELU)
NASDAQ: CELU · Real-Time Price · USD
2.940
+0.020 (0.68%)
At close: Nov 20, 2024, 4:00 PM
2.820
-0.120 (-4.08%)
After-hours: Nov 20, 2024, 7:47 PM EST

Celularity Revenue

Celularity had revenue of $12.11M in the quarter ending June 30, 2024, with 312.22% growth. This brings the company's revenue in the last twelve months to $42.69M, up 182.02% year-over-year. In the year 2023, Celularity had annual revenue of $22.77M with 26.68% growth.

Revenue (ttm)
$42.69M
Revenue Growth
+182.02%
P/S Ratio
1.40
Revenue / Employee
$355,750
Employees
120
Market Cap
64.70M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 202322.77M4.80M26.68%
Dec 31, 202217.98M-3.36M-15.75%
Dec 31, 202121.34M7.06M49.43%
Dec 31, 202014.28M-6.87M-32.48%
Dec 31, 201921.15M3.59M20.47%
Dec 31, 2018 Pro Pro Pro
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Xtant Medical Holdings 113.86M
Spero Therapeutics 106.46M
OptiNose 75.67M
Champions Oncology 51.66M
Hyperfine 13.26M
VolitionRx 1.29M
Entera Bio 99.00K
Revenue Rankings

CELU News

More News